The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med333: 1581–1587, 1995.
2.
FurlanAHigashidaR: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA282: 2003–2011, 1999.
3.
HackeWKasteM: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA274: 1017–1025, 1995.
4.
HackeWKasteM: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European Australasian Acute Stroke Study Investigators. Lancet352 (9136): 1245–1251, 1998.
5.
BaronJCvon KummerR: Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time-window. Stroke26: 2219–2221, 1995.
6.
von KummerRBourquainH: Early prediction of irreversible brain damage after ischemic stroke by Computed Tomography. Radiology219 (1): 95–100, 2001.
7.
von KummerRHolleR: Interob-server agreement in assessing early CT signs of middle cerebral artery infarction. Am J Neuroradiol17 (9): 1743, 1996.
8.
von KummerRAllenKL: Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology205 (2): 327–333, 1997.
9.
WarachSGaaJ: Acute human stroke studied by whole brain echo planar diffusion-weighted MRI. Ann Neurol37: 231–241, 1995.
10.
Le BihanDBretonE: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology161: 401–407, 1986.
11.
WarachS: Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Current trials in cardiovascular medicine (1): 38–44, 2001.
12.
SchellingerPDJansenO: A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke30 (4): 765–768, 1999.
13.
SchellingerPDJansenO: Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. Am J Neuroradiol21 (7): 1184–1189, 2000.
14.
LovbladKLaubachH: Clinical experience with diffusion-weighted MR in patients with acute stroke. Am J Neuroradiol19: 1061–1066, 1998.
15.
GonzalezRGSchaeferPW: Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology210 (1): 155–162.
16.
LovbladKOBairdAE: Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol42 (2): 164–170, 1997.
17.
JansenOSchellingerP: Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet353: 2036–2037, 1999.
18.
TalebMLovbladKO: Reperfusion demonstrated by apparent diffusion coefficient mapping after local intra-arterial thrombolysis for ischaemic stroke. Neuroradiology43 (7): 591–594, 2001.
19.
KidwellCSSaverJL: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol47 (4): 462–469, 2000.
20.
OppenheimCStanescuR: False-negative diffusion-weighted MR findings in acute ischemic stroke. Am J Neuroradiol21 (8): 1434–1340, 2000.
21.
MamataYMamataH: Intraoperative diffusion imaging on a 0.5 Tesla interventional scannerJ MRI13 (1): 115–119, 2001.
